Literature DB >> 16146773

VEGFR-1 and VEGFR-2: two non-identical twins with a unique physiognomy.

Nader Rahimi1.   

Abstract

Angiogenesis involves endothelial cell differentiation, proliferation, migration and cord formation, which lead to tubulogenesis to form vessels. One group of growth factor receptors implicated in angiogenesis is the VEGFR family of receptor tyrosine kinases. VEGFR-1 and VEGFR-2 are closely related receptor tyrosine kinases and have both common and specific ligands. VEGFR-1 is a kinase-impaired RTK whereas VEGFR-2 is a highly active kinase. Despite their differential kinase activation potentials, both VEGFR-1 and VEGFR-2 are required for normal development and angiogenesis. VEGFR-1 regulates angiogenesis by mechanisms that involve ligand-trapping, receptor homo- and heterodimerization. VEGFR-2 stimulates variety of signaling pathways and broad biological responses in vitro. The mechanisms that govern VEGFR-2 activation, its ability to recruit signaling proteins and to undergo downregulation are highly regulated by its carboxyl terminus. This review highlights recent insights into the mechanism of activation of VEGFR-1 and VEGFR-2, and focuses on the signaling pathways employed by VEGFR-1 and VEGFR-2 that regulate angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16146773      PMCID: PMC1360224          DOI: 10.2741/1839

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  79 in total

1.  Deletion of the carboxyl terminus of Tie2 enhances kinase activity, signaling, and function. Evidence for an autoinhibitory mechanism.

Authors:  Xi-Lin Niu; Kevin G Peters; Christopher D Kontos
Journal:  J Biol Chem       Date:  2002-06-24       Impact factor: 5.157

2.  Signal transduction. Autoinhibition control.

Authors:  Joseph Schlessinger
Journal:  Science       Date:  2003-05-02       Impact factor: 47.728

3.  Crystal structure of the MuSK tyrosine kinase: insights into receptor autoregulation.

Authors:  Jeffrey H Till; Manuel Becerra; Anke Watty; Yun Lu; Yuliang Ma; Thomas A Neubert; Steven J Burden; Stevan R Hubbard
Journal:  Structure       Date:  2002-09       Impact factor: 5.006

4.  Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins.

Authors:  Akulapalli Sudhakar; Hikaru Sugimoto; Changqing Yang; Julie Lively; Michael Zeisberg; Raghu Kalluri
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-07       Impact factor: 11.205

5.  The presence of a single tyrosine residue at the carboxyl domain of vascular endothelial growth factor receptor-2/FLK-1 regulates its autophosphorylation and activation of signaling molecules.

Authors:  Rosana D Meyer; Volkan Dayanir; Fredric Majnoun; Nader Rahimi
Journal:  J Biol Chem       Date:  2002-05-22       Impact factor: 5.157

6.  Recruitment and activation of phospholipase Cgamma1 by vascular endothelial growth factor receptor-2 are required for tubulogenesis and differentiation of endothelial cells.

Authors:  Rosana D Meyer; Catharina Latz; Nader Rahimi
Journal:  J Biol Chem       Date:  2003-02-21       Impact factor: 5.157

Review 7.  The role of neuropilin in vascular and tumor biology.

Authors:  Michael Klagsbrun; Seiji Takashima; Roni Mamluk
Journal:  Adv Exp Med Biol       Date:  2002       Impact factor: 2.622

Review 8.  The deaf and the dumb: the biology of ErbB-2 and ErbB-3.

Authors:  Ami Citri; Kochupurakkal Bose Skaria; Yosef Yarden
Journal:  Exp Cell Res       Date:  2003-03-10       Impact factor: 3.905

Review 9.  Vascular growth factors and lymphangiogenesis.

Authors:  Lotta Jussila; Kari Alitalo
Journal:  Physiol Rev       Date:  2002-07       Impact factor: 37.312

10.  Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability.

Authors:  Teresa Odorisio; Cataldo Schietroma; M Letizia Zaccaria; Francesca Cianfarani; Cecilia Tiveron; Laura Tatangelo; Cristina M Failla; Giovanna Zambruno
Journal:  J Cell Sci       Date:  2002-06-15       Impact factor: 5.285

View more
  75 in total

1.  Endothelial-derived hyperpolarization factor (EDHF) contributes to PlGF-induced dilation of mesenteric resistance arteries from pregnant rats.

Authors:  Maurizio Mandalà; Natalia Gokina; Carolyn Barron; George Osol
Journal:  J Vasc Res       Date:  2011-10-06       Impact factor: 1.934

2.  Selective Imaging of VEGFR-1 and VEGFR-2 Using 89Zr-Labeled Single-Chain VEGF Mutants.

Authors:  Jan-Philip Meyer; Kimberly J Edwards; Paul Kozlowski; Marina V Backer; Joseph M Backer; Jason S Lewis
Journal:  J Nucl Med       Date:  2016-07-07       Impact factor: 10.057

3.  The impact of tumor receptor heterogeneity on the response to anti-angiogenic cancer treatment.

Authors:  Ding Li; Stacey D Finley
Journal:  Integr Biol (Camb)       Date:  2018-04-23       Impact factor: 2.192

4.  Regulation of angiogenesis by histone chaperone HIRA-mediated incorporation of lysine 56-acetylated histone H3.3 at chromatin domains of endothelial genes.

Authors:  Debasree Dutta; Soma Ray; Pratik Home; Biswarup Saha; Shoujian Wang; Nader Sheibani; Osama Tawfik; Niki Cheng; Soumen Paul
Journal:  J Biol Chem       Date:  2010-11-01       Impact factor: 5.157

5.  Selective Imaging of Vascular Endothelial Growth Factor Receptor-1 and Receptor-2 in Atherosclerotic Lesions in Diabetic and Non-diabetic ApoE-/- Mice.

Authors:  Yared Tekabe; Lynne L Johnson; Krissy Rodriquez; Qing Li; Marina Backer; Joseph M Backer
Journal:  Mol Imaging Biol       Date:  2018-02       Impact factor: 3.488

6.  Knockdown of VEGF receptor-1 (VEGFR-1) impairs macrophage infiltration, angiogenesis and growth of clear cell renal cell carcinoma (CRCC).

Authors:  Chenghai Li; Bin Liu; Zonghan Dai; Yunxia Tao
Journal:  Cancer Biol Ther       Date:  2011-11-15       Impact factor: 4.742

7.  Vascular endothelial growth factor (VEGF)-A: role on cardiac angiogenesis following myocardial infarction.

Authors:  Tieqiang Zhao; Wenyuan Zhao; Yuanjian Chen; Robert A Ahokas; Yao Sun
Journal:  Microvasc Res       Date:  2010-04-01       Impact factor: 3.514

8.  Expression of semaphorin 6D and its receptor plexin-A1 in gastric cancer and their association with tumor angiogenesis.

Authors:  Yanjie Lu; Qian Xu; Lei Chen; Yanzhen Zuo; Shaochen Liu; Yatao Hu; Xiaoru Li; Yuhong Li; Xiangyang Zhao
Journal:  Oncol Lett       Date:  2016-09-29       Impact factor: 2.967

9.  FLT1 genetic variation predisposes to neovascular AMD in ethnically diverse populations and alters systemic FLT1 expression.

Authors:  Leah A Owen; Margaux A Morrison; Jeeyun Ahn; Se Joon Woo; Hajime Sato; Rosann Robinson; Denise J Morgan; Fani Zacharaki; Marina Simeonova; Hironori Uehara; Usha Chakravarthy; Ruth E Hogg; Balamurali K Ambati; Maria Kotoula; Wolfgang Baehr; Neena B Haider; Giuliana Silvestri; Joan W Miller; Evangelia E Tsironi; Lindsay A Farrer; Ivana K Kim; Kyu Hyung Park; Margaret M DeAngelis
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-08       Impact factor: 4.799

10.  Anti-angiogenic effects of differentiation-inducing factor-1 involving VEGFR-2 expression inhibition independent of the Wnt/β-catenin signaling pathway.

Authors:  Tatsuya Yoshihara; Fumi Takahashi-Yanaga; Fumie Shiraishi; Sachio Morimoto; Yutaka Watanabe; Masato Hirata; Sumio Hoka; Toshiyuki Sasaguri
Journal:  Mol Cancer       Date:  2010-09-16       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.